Because the CONCERTA tablet is nondeformable and does not appreciably improve in shape while in the GI tract, CONCERTA must not ordinarily be administered to patients with preexisting extreme gastrointestinal narrowing (pathologic or iatrogenic, for example: esophageal motility Issues, compact bowel inflammatory illness, "limited intestine" syndrom